In a context of growing concern for France's health sovereignty, the Nîmes University Hospital and MB Therapeutics are partnering to offer innovative medical solutions, better adapted to the specific needs of patients, while diversifying therapeutic options beyond standard treatments.

Personalized next-generation medications

This new partnership makes it possible to optimize standardized oral forms, particularly for children and the elderly, by offering individualized solutions to swallowing problems or precise adjustments to posology and dosage.

This latest generation technology precisely personalizes treatments taking into account the age, physical condition and special needs of patients.

Medications manufactured, in situ, at the Nîmes University Hospital

The manufacture of these unique medications, which guarantee better management and greater effectiveness of care, is based on the use of an industrial-grade pharmaceutical 3D printer, capable of producing them directly in a dedicated unit of the Nîmes University Hospital: the UPM (Unit of Production of Medications).

For medical professionals, this innovation brings significant benefits. Manual preparations, often repetitive, can be carried out by automated processes, under supervision. This reduces the risk of errors and the time spent on these tasks, thereby allowing teams to focus on their core business: personalized support for patients and continuous improvement of their care.

A shared commitment to strengthen the national pharmaceutical industry

This alliance aims to improve the University Hospital's capacity to produce its own medications, thus contributing to better security of supply at the local and national levels. In a context of fragility in global supply chains, it promotes the development of local and more resilient pharmaceutical production.

About Nîmes University Hospital:

The University Hospital Center (CHU) of Nîmes brings together a hospital community of 1,397 doctors and 5,963 non-medical professionals. It consists of three main sites: the Carémeau university hospital campus, the Serre Cavalier university gerontology hospital, and the University Rehabilitation, Re-education and Addictology Hospital in Grau-du-Roi. Its fundamental missions include care, teaching, research, and innovation. The CHU is also engaged in prevention, health education and access to care. https://www.chu-nimes.fr/

The press release to find: innovative partnership_MB Therapeutics&CHU Nîmes